Product logins

Find logins to all Clarivate products below.


Transcatheter Embolization and Occlusion Devices – Market Insights – Latin America

The Latin American TEO device market is poised to experience moderate growth through 2034. This growth will be driven by the introduction of newly developed technologies, increasing adoption of innovative devices backed by strong clinical evidence, and a rise in procedure volumes.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for TEO devices in Latin America from 2019 through 2034.

Companies are releasing new devices and better versions of existing ones to stay ahead in the growing market.

How are established players leveraging next-generation product launches to defend market share and differentiate from emerging competitors?

Which new companies are planning to enter the TEO device market in the Latin American region?

What difficulties might these new companies face? Will they be able to take a large share of the market from current players?

What design improvements or clinical features are driving the appeal of upgraded TEO devices?

Clinical data will play an important role in driving the adoption of TEO devices.

Which clinical trials were recently conducted in this market?

What is the expected impact of these clinical trials on market dynamics?

Emergence of evidence supporting use of embolization devices in the treatment of chronic subdural hematoma will support TEO procedure volume growth.

Which embolization devices will see the strongest adoption in the treatment of chronic subdural hematoma?

How will the uptake of embolization procedures in the treatment of chronic subdural hematoma vary across the Latin American region?

Flow-diverting devices are contributing to growth in the Latin American TEO device market.

How will the adoption of flow-diverting devices impact the neurovascular embolization coil and coiling-assist device markets?

Which strategies are competitors adopting to gain a competitive edge over other competitors in the flow-diverting device market?

What will be the impact of emergence of new competitors and products in the Latin American TEO device market?

Table of contents


Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Latin America
The Latin American biosurgical agent market will grow modestly through 2034; although demand for biosurgical agents will rise—supported by favorable regional demographics, expanded indication…
Report
Urological Devices – Market Insights – Latin America
The Latin American urological device market will continue to expand through 2034, driven by the rising prevalence of kidney stones and UI, aging populations, and growing patient awareness of…
Report
Structural Heart Closure Devices – Market Insights – Asia Pacific
The Asia Pacific structural heart closure device market will grow strongly overall through 2034, supported by rising AF prevalence, increasing physician confidence in structural heart interventions…
Report
Interventional Oncology Devices – Market Insights – Latin America
The Latin American interventional oncology device market will see moderate growth through 2034, driven by a large and rapidly expanding patient pool, improving access to treatment, and the entry of…
Report
Coronary Artery Bypass Graft Devices – Market Insights – United States
The US CABG device market will be supported by sustained demand for surgical revascularization in patients with increasingly complex CAD, where CABG remains the preferred treatment option…